Who we work with
PHGA collaborates with leaders and institutions shaping the future of precision health and genomics, supporting decision‑makers across business, academia, healthcare, and the advisory sector.
PHGA works with leaders and institutions across business, academia, healthcare, and the advisory sector.
Business Leaders, Founders & Investors
Entrepreneurs, CEOs, board members, and investors rely on PHGA to evaluate genomic opportunities and design viable strategies, with advisory insight on venture development, due diligence, and cross‑border growth between the United States and Latin America.
Examples:
- Assessing scientific and market feasibility of genomic ventures.
- Designing business models and implementation roadmaps for new services.
- Understanding regional dynamics, regulation, and partnerships for expansion.
Entrepreneurs, CEOs, board members, and investors rely on PHGA to assess genomic opportunities, shape viable strategies, and support cross-border growth between the United States and Latin America.
Examples:
• Evaluating genomic venture opportunities.
• Designing business models and expansion strategies.
Academic, clinical, and research institutions.
Universities, medical schools, hospitals, and research centers partner with PHGA to build and strengthen their genomic medicine capabilities. Through precision health and genomics advisory projects, PHGA helps institutions design programs, curricula, and collaborations that integrate genomics into clinical care, education, and public health.
Examples:
- Creating or expanding genomic medicine programs and service portfolios.
- Developing training pathways for clinicians, scientists, and technical staff.
- Structuring international research and education collaborations.
Universities, hospitals, and research centers work with PHGA to strengthen genomic medicine capabilities across clinical care, education, and public health.
Examples:
• Building genomic medicine programs and services.
• Developing training and international collaborations.
Consulting, legal, and advisory firms.
Generalist consulting, legal, and advisory firms engage Precision Health & Genomics Advisory as a subject-matter expert in genomics and precision health. PHGA integrates seamlessly into multi-disciplinary teams, providing specialized analysis and recommendations that enhance broader strategy, transaction, or policy projects.
Examples:
- Technical and scientific input for healthcare and life sciences projects.
- Precision health and genomics advisory support during strategy, policy, or investment engagements.
- Co-developing frameworks, white papers, or recommendations for client leadership.
Consulting, legal, and advisory firms engage PHGA as a genomics and precision health subject-matter expert for multidisciplinary projects.
Examples:
• Technical and scientific input for healthcare and life sciences projects.
• Precision health and genomics support for strategy, policy, or investment work.
Biotech, diagnostics, and healthtech companies.
Companies developing molecular diagnostics, digital platforms, and enabling technologies partner with PHGA to align science, regulation, and business strategy. Precision Health & Genomics Advisory supports product and service design, validation planning, and regional expansion.
Examples:
- Positioning new genomic tests and platforms in competitive markets.
- Planning validation, quality, and implementation strategies.
- Exploring cross-border commercialization opportunities and partnerships.
Companies in biotech, diagnostics, and healthtech partner with PHGA to align science, regulation, and business strategy in product design, validation, and regional expansion.
Examples:
• Positioning new genomic tests and platforms in competitive markets.
• Planning validation, implementation, and regional expansion strategies.
Governmental and multilateral institutions.
Agencies and international organizations call on PHGA for precision health and genomics advisory input on policy, strategy, and innovation agendas. The firm contributes scientific, technical, and ecosystem perspectives to initiatives focused on population health, bioeconomy, and health innovation.
Examples:
- Advisory support for national or regional genomics and precision medicine strategies.
- Expert participation in committees, working groups, and strategic reviews.
- Program design for capacity building and cross-border collaboration.
Agencies and international organizations rely on PHGA for advisory input on precision health, genomics, policy, strategy, and innovation.
Examples:
- Advisory support for genomics and precision medicine strategies.
- Program design for capacity building and cross-border collaboration.
Across these sectors, PHGA builds bridges between science, innovation, and implementation, helping clients move confidently from vision to action in precision health and genomics.
Across these sectors, PHGA helps turn vision into action in precision health and genomics.